Literature DB >> 15663017

Is there a role for living donor intestine transplants?

Jonathan Fryer1, Peter Angelos.   

Abstract

The use of living donors with intestinal transplantation is controversial because it may not significantly improve candidate access to organs when intestine-only grafts are needed, and may involve excessive donor risk when combined liver-intestine grafts are required. Although limited data are available for comparison at this time, graft and patient survival rates for intestinal transplantations using living donors are no different than for deceased donor transplantations. Potential benefits that may be provided to the intestine transplant recipient through the use of living donors include better HLA matching, shorter ischemia times, better bowel preparation, and better opportunities for introducing immunomodulatory strategies. Conversely, living intestine donors are at risk for mortality, significant morbidity, financial loss, and psychologic trauma. The long-term outcomes of living intestine donors have not yet been reported. Ultimately, these data are essential before the wider use of living donors can be advocated for intestinal transplantation.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2004        PMID: 15663017     DOI: 10.1177/152692480401400407

Source DB:  PubMed          Journal:  Prog Transplant        ISSN: 1526-9248            Impact factor:   1.065


  3 in total

Review 1.  Where are we at with short bowel syndrome and small bowel transplant.

Authors:  Baris Dogu Yildiz
Journal:  World J Transplant       Date:  2012-12-24

2.  Intestinal failure: a viable proposition in India.

Authors:  Frederick Vyas; Benjamin Perakath
Journal:  Indian J Gastroenterol       Date:  2012-09-06

3.  Living related segmental bowel transplantation: from experimental to standardized procedure.

Authors:  Enrico Benedetti; Mark Holterman; Massimo Asolati; Stefano Di Domenico; José Oberholzer; Howard Sankary; Herand Abcarian; Giuliano Testa
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.